Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyllevocarnitine for Diabetic Peripheral Neuropathy (China Phase 3)
CTR20200026Phase 3Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetyl-l-carnitine in diabetic polyneuropathy (DPN), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Jan 2020; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20200026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200026.